Conning Inc. Eli Lilly & CO Transaction History

Conning Inc.

$2.89 Billion
Q3 2024

A detailed history of Conning Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Conning Inc. holds 10,204 shares of LLY stock, worth $7.65 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

10,204

Previous 10,574 3.5%

Holding current value

$7.65 Million

Previous $9.57 Million 5.57%

% of portfolio

0.31%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$772.14 - $960.02 $285,691 - $355,207	-370 Reduced 3.5%	10,204 $9.04 Million
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $636,435 - $798,137	-878 Reduced 7.67%	10,574 $9.57 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $527,058 - $705,129	-890 Reduced 7.21%	11,452 $8.91 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $44,115 - $52,006	-84 Reduced 0.68%	12,342 $7.19 Million
Q3 2023 Oct 26, 2023	SELL	$434.7 - $599.3 $726,383 - $1 Million	-1,671 Reduced 11.85%	12,426 $6.67 Million
Q2 2023 Jul 21, 2023	BUY	$350.74 - $468.98 $2.77 Million - $3.71 Million	7,902 Added 127.55%	14,097 $6.61 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $30.3 Million - $35.6 Million	-97,570 Reduced 94.03%	6,195 $2.13 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $4.51 Million - $5.26 Million	-14,027 Reduced 11.91%	103,765 $38 Million
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $8.61 Million - $9.81 Million	-29,045 Reduced 19.78%	117,792 $38.1 Million
Q2 2022 Jul 20, 2022	SELL	$278.73 - $327.27 $9.52 Million - $11.2 Million	-34,146 Reduced 18.87%	146,837 $47.5 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $4.53 Million - $5.63 Million	-19,297 Reduced 9.64%	180,983 $51.8 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $277,464 - $344,335	-1,234 Reduced 0.61%	200,280 $55.3 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $12.9 Million - $15.9 Million	-58,145 Reduced 22.39%	201,514 $46.5 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $3.26 Million - $4.22 Million	18,051 Added 7.47%	259,659 $59.6 Million
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $37.8 Million - $48.9 Million	229,895 Added 1962.73%	241,608 $45.1 Million
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $113,369 - $150,015	-869 Reduced 6.91%	11,713 $1.98 Million
Q3 2020 Oct 21, 2020	BUY	$146.22 - $169.13 $10,235 - $11,839	70 Added 0.56%	12,582 $1.86 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $25,237 - $30,373	-185 Reduced 1.46%	12,512 $2.05 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $40,953 - $50,688	-344 Reduced 2.64%	12,697 $1.76 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $89,812 - $111,241	-840 Reduced 6.05%	13,041 $1.71 Million
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $83,723 - $91,069	-784 Reduced 5.35%	13,881 $1.55 Million
Q2 2019 Jul 25, 2019	SELL	$110.79 - $129.32 $345,332 - $403,090	-3,117 Reduced 17.53%	14,665 $1.63 Million
Q1 2019 Apr 22, 2019	SELL	$111.31 - $131.02 $27,827 - $32,755	-250 Reduced 1.39%	17,782 $2.31 Million
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $218,154 - $244,398	-2,060 Reduced 10.25%	18,032 $2.09 Million
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $155,406 - $194,231	-1,810 Reduced 8.26%	20,092 $2.16 Million
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $58,289 - $66,897	-770 Reduced 3.4%	21,902 $1.87 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $194,430 - $229,511	-2,620 Reduced 10.36%	22,672 $1.75 Million
Q4 2017 Jan 30, 2018	BUY	$81.94 - $87.89 $167,157 - $179,295	2,040 Added 8.77%	25,292 $2.14 Million
Q3 2017 Oct 20, 2017	BUY	$77.07 - $85.54 $1.79 Million - $1.99 Million	23,252	23,252 $1.99 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account